Author:
McLeod David,Zinner Norman,Tomera Kevin,Gleason Donald,Fotheringham Nick,Campion Marilyn,Garnick Marc B
Reference5 articles.
1. Abarelix depot, a GnRH antagonist, vs leuprolide or goserelin, LHRH agonists;Tomera;J Urol,2001
2. Garnick MB, Tomera K, Campion M, et al: Abarelix-depot (A-D), a sustained release (SR) formulation of a potent GnRH pure antagonists in patients (pts) with prostate cancer (PrCA): phase II clinical results and endocrine comparison with agonists Lupron (L) and Zoladex (Z) (abstract). J Urol 161(4 suppl): 340, 1999.
3. Abarelix depot-M, a GnRH superagonist, versus LHRH superagonists in prostate cancer;Garnick;Mol Urol,2000
4. Garnick MB, Gittleman M, Steidle C, et al: Abarelix (PPI-149), a novel and potent GnRH antagonist, induces a rapid and profound prostate gland volume reduction (PGVR) and androgen suppression before brachytherapy (BT) or radiation therapy (XPT) (abstract). J Urol 159(5 suppl): 220, 1998.
5. Hormone-refractory prostate cancer cells express functional follicle-stimulating hormone receptor (FSHR);Ben-Josef;J Urol,1999
Cited by
140 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献